DAB-4HCl, Immunochemical Grade, 10mg Lyophilized per vial
C12H14N4 · 4HCl
Polysciences’ 3, 3’-Diaminobenzidine Tetrahydrochloride is manufactured to the highest standards with a strong emphasis on experimenter safety. Our DAB•4HCl comes lyophilized in 10mg portions per serum vial. Buffer can be added directly to the DAB serum vial with a hypodermic syringe, thereby significantly reducing product contact and enhancing safety.
Our DAB•4HCl is the chromogen of choice for immunoperoxidase techniques. It is fully water soluble and may be used without need for further purification. The brown reaction product is highly insoluble and will not diffuse from the site of localization. The color does not fade, and therefore, slides can be saved as permanent record. The reaction product also chelates with osmium tetroxide and becomes electron dense for use in electron microscopy.
10mg Lyophilized DAB•4HCl per vial.
Key Advantages:
- Safety focused
- Easy to use
- Manufactured to ISO 13485:2016
Choi, J.-H., Riew, T.-R., Kim, H. L., Jin, X., & Lee, M.-Y. (2017). Desmin expression profile in reactive astrocytes in the 3-nitropropionic acid–lesioned striatum of rat: Characterization and comparison with glial fibrillary acidic protein and nestin. Acta Histochemica, 119(8), 795–803.
Gray, S. J., Matagne, V., Bachaboina, L., Yadav, S., Ojeda, S. R., & Samulski, R. J. (2011). Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates. Molecular Therapy, 19(6), 1058–1069.
Hayes, D. M., Deeny, M. A., Shaner, C. A., & Nixon, K. (2013). Determining the Threshold for Alcohol-Induced Brain Damage: New Evidence with Gliosis Markers. Alcoholism: Clinical and Experimental Research, 37(3), 425–434.
Gray, S. J., Nagabhushan Kalburgi, S., McCown, T. J., & Jude Samulski, R. (2013). Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Therapy, 20(4), 450–459.
Geisler, H. E., Geisler, J. P., Miller, G. A., Geisler, M. J., Wiemann, M. C., Zhou, Z., & Crabtree, W. (2001). p21 and p53 in ovarian carcinoma. Cancer, 92(4), 781–786.
